Is this infant formula company the next a2 Milk Company?

Is Nuchev Limited (ASX:NUC) the next A2 Milk Company Ltd (ASX:A2M)?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has now been one month since the Nuchev Limited (ASX: NUC) share price landed on the ASX boards following its successful IPO.

In light of this, I thought I would check in and see how the goat milk infant formula company has performed since its listing at $2.60 per share.

How is the Nuchev share price performing?

The Nuchev share price has been a very strong performer since its IPO in December.

On Thursday the company's shares rose 4% to $3.60. This means it is now up $1.00 or over 38% since landing on the ASX boards.

Why are investors buying Nuchev's shares?

Investors appears to have been buying shares in the hope that it becomes the next A2 Milk Company Ltd (ASX: A2M) or Bubs Australia Ltd (ASX: BUB).

Whether or not it will achieve this, only time will tell, but it certainly does have a lot going for itself.

Nuchev is an infant formula company that was founded by Ben Dingle in 2013. Mr Dingle is the co-founder of Synlait Milk Ltd (ASX: SM1), which is best known as the processing partner of A2 Milk Company.

Its primary products are its Oli6 branded goat milk infant formula range. It sells these across multiple sales channels in Australia, China, and Hong Kong.

The Oli6 product has been formulated specifically for the needs of infants and children. Management notes that the potential health benefits of the range are supported by scientific laboratory research published by RMIT University researchers.

How big could it grow?

At present Nuchev has a market capitalisation of ~$160 million, based on its 45 million shares outstanding.

This is only a fraction of the size of its global market opportunity. According to its prospectus, the global goat milk infant formula market is expected to grow at a compound annual growth rate of 16.6% from $6.3 billion in 2018 to $13.6 billion in 2023.

Nuchev is specifically targeting the Chinese goat milk infant formula market, which is growing even quicker and expected to be worth $9.2 billion by 2023.

If the company can win a decent slice of this market then there could be plenty of upside for its shares. Though, it might be worth waiting to see how it has performed in the December quarter before making a move.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a nervous, but positive, Tuesday for ASX investors.

Read more »

two colleagues high five each other as they sit side by side at a long desk in front of their laptop computers in an office environment.
Share Gainers

Why Bapcor, Ramelius, Sandfire, and WIA Gold shares are rising today

These shares are having a better day than most on Tuesday. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors started the week off in a good mood today.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Bellevue Gold, Bubs, Clarity Pharmaceuticals, and Regal Partners shares are rising today

These shares are starting the week on a positive note.

Read more »

Two people lazing in deck chairs on a beautiful sandy beach throw their hands up in the air.
Travel Shares

Guess which ASX All Ords travel stock just rocketed 17% on an earnings upgrade

Investors are piling into the ASX All Ords travel stock today. Here's what's happening.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Fortescue, Lynas, PEXA, and Regis Healthcare shares are charging higher

These shares are having a strong session on Thursday. But why?

Read more »